Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Clinical Implications: What This Means for Patients As I consider the landmark Afrin study findings alongside the broader anti-inflammatory research, I'm struck by the potential implications for patients with: Mast cell activation syndrome and related histamine-mediated conditions (read about my 9 Powerful Treatments for MCAS) now with compelling evidence showing 89% clinical improvement rates Autoimmune diseases involving chronic inflammation (learn about the connection between infections and autoimmune conditions) Neuroinflammatory conditions including chronic pain syndromes Cardiovascular disease with inflammatory components Chronic fatigue potentially linked to inflammatory processes (explore how hidden infections may be causing your fatigue and the fascinating similarities between Long COVID and chronic fatigue) Thyroid dysfunction , particularly Hashimoto's thyroiditis and other inflammatory thyroid conditions The Afrin study researchers emphasize that randomized controlled trials are needed to fully assess efficacy and identify optimal dosing protocols for GLP-1 receptor agonist treatment in MCAS and other inflammatory conditions
However, some people find that taking high doses of glutathione over a long period can affect their zinc levels
(*excludes NAD+ drips) NAD+ Therapy In addition to IV nutrient therapy, we offer NAD+ therapy drips
Gastroesophageal reflux disease is listed among common adverse reactions in the FDA prescribing information for Zepbound
